Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
5/8/2026, 12:00:00 AM
The European Commission granted approval for Sotyktu (deucravacitinib) for the treatment of active psoriatic arthritis in adults, announced on May 8, 2026. No market reaction yet; medium impact estimated due to expansion into the European market, scheduled.
Korean Translation
2026년 5월 8일 유럽연합 집행위원회로부터 소틱투 판매 허가를 받을 예정임. 아직 시장 반응이 없으나, 유럽 시장 확대에 따른 중간 수준의 시장 영향이 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM